A new trading day began on Friday, with Immunovant Inc (NASDAQ: IMVT) stock price up 3.88% from the previous day of trading, before settling in for the closing price of $13.92. IMVT’s price has ranged from $12.72 to $34.47 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged -49.30%. With a float of $68.14 million, this company’s outstanding shares have now reached $147.20 million.
Let’s look at the performance matrix of the company that is accounted for 207 employees. In terms of profitability, gross margin is 90.4%, operating margin of -27013.67%, and the pretax margin is -25478.07%.
Immunovant Inc (IMVT) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Immunovant Inc is 60.07%, while institutional ownership is 56.09%. The most recent insider transaction that took place on Apr 23 ’25, was worth 28,471. In this transaction Chief Technology Officer of this company sold 1,925 shares at a rate of $14.79, taking the stock ownership to the 209,243 shares. Before that another transaction happened on Apr 23 ’25, when Company’s Chief Medical Officer sold 2,349 for $14.79, making the entire transaction worth $34,742. This insider now owns 225,370 shares in total.
Immunovant Inc (IMVT) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.73 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -49.30% per share during the next fiscal year.
Immunovant Inc (NASDAQ: IMVT) Trading Performance Indicators
Here are Immunovant Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 6.04.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.62, a number that is poised to hit -0.71 in the next quarter and is forecasted to reach -2.99 in one year’s time.
Technical Analysis of Immunovant Inc (IMVT)
Immunovant Inc (NASDAQ: IMVT) saw its 5-day average volume 1.04 million, a negative change from its year-to-date volume of 1.59 million. As of the previous 9 days, the stock’s Stochastic %D was 29.63%. Additionally, its Average True Range was 0.94.
During the past 100 days, Immunovant Inc’s (IMVT) raw stochastic average was set at 12.66%, which indicates a significant decrease from 35.71% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 59.93% in the past 14 days, which was lower than the 62.69% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $16.25, while its 200-day Moving Average is $24.22. Nevertheless, the first resistance level for the watch stands at $14.75 in the near term. At $15.04, the stock is likely to face the second major resistance level. The third major resistance level sits at $15.56. If the price goes on to break the first support level at $13.94, it is likely to go to the next support level at $13.42. The third support level lies at $13.13 if the price breaches the second support level.
Immunovant Inc (NASDAQ: IMVT) Key Stats
With a market capitalization of 2.46 billion, the company has a total of 169,861K Shares Outstanding. Currently, annual sales are 0 K while annual income is -259,340 K. The company’s previous quarter sales were 0 K while its latest quarter income was -111,120 K.
